Aziz Nazha Selected Research

Aziz Nazha Research Topics

Disease

19	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021 - 08/2012
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2022 - 02/2015
9	Neoplasms (Cancer) 01/2021 - 02/2015
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 05/2012
4	Leukemia 11/2021 - 01/2017
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2022 - 02/2015
3	Primary Myelofibrosis (Myelosclerosis) 09/2016 - 10/2015
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 11/2021
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 10/2015
2	Thrombosis (Thrombus) 09/2016 - 04/2016
2	Polycythemia Vera 09/2016 - 04/2016
1	Chronic Brain Damage 04/2022
1	Invasive Fungal Infections 04/2022
1	Renal Insufficiency (Renal Failure) 04/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2022
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022
1	COVID-19 08/2021
1	Coronavirus Infections 08/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2018
1	Anemia 01/2018
1	Neutropenia 01/2018
1	Splenomegaly 09/2016
1	Multiple Myeloma 02/2015
1	Hemorrhage 10/2013
1	Down Syndrome (Down's Syndrome) 09/2013
1	Hairy Cell Leukemia 02/2013

Drug/Important Bio-Agent (IBA)

4	Biological ProductsIBA 12/2019 - 09/2013
4	Tyrosine Kinase InhibitorsIBA 11/2013 - 05/2012
3	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2021 - 11/2013
3	Azacitidine (5 Azacytidine)FDA Link 08/2017 - 06/2013
2	LigandsIBA 11/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2019
2	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2021 - 01/2019
2	Hydroxyurea (Hydrea)FDA LinkGeneric 09/2016 - 04/2016
1	P-2 (P 2)IBA 04/2022
1	Hemoglobins (Hemoglobin)IBA 11/2021
1	Immunoglobulins (Immunoglobulin)IBA 11/2021
1	alvocidib (flavopiridol)IBA 10/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2021
1	CXC ChemokinesIBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	SirtuinsIBA 01/2020
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020
1	IMP DehydrogenaseIBA 01/2020
1	ixazomibIBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	IodineIBA 01/2018
1	ON 01910IBA 12/2017
1	Vorinostat FDA Link 08/2017
1	Lenalidomide (CC 5013)FDA Link 08/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	ruxolitinibIBA 09/2016
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 10/2015
1	CollagenIBA 10/2015
1	Reticulin (Reticular Fiber)IBA 10/2015
1	midostaurinIBA 04/2015
1	MDS 11IBA 02/2015
1	Clofarabine (Clolar)FDA Link 11/2013
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2013
1	NucleosidesIBA 11/2013
1	InterferonsIBA 10/2013
1	ponatinibIBA 10/2013
1	HomoharringtonineIBA 10/2013
1	NucleophosminIBA 08/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2013
1	Sorafenib (BAY 43-9006)FDA Link 06/2013
1	Rituximab (Mabthera)FDA Link 02/2013
1	purineIBA 02/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2013
1	fms-Like Tyrosine Kinase 3IBA 08/2012
1	Tyrosine (L-Tyrosine)FDA Link 08/2012
1	Imatinib Mesylate (Gleevec)FDA Link 05/2012

Therapy/Procedure

15	Therapeutics 01/2021 - 10/2013
5	Cell Transplantation 03/2022 - 01/2019
4	Drug Therapy (Chemotherapy) 12/2019 - 01/2013
1	Donor Selection 03/2022
1	Homologous Transplantation 01/2022
1	MDC protocol 01/2022
1	Length of Stay 08/2021
1	Ambulatory Care (Outpatient Care) 01/2021
1	Hematopoietic Stem Cell Transplantation 11/2020
1	Thyroidectomy 01/2018
1	Precision Medicine 01/2017
1	Complementary Therapies (Alternative Medicine) 04/2016
1	Aftercare (After-Treatment) 02/2016
1	Induction Chemotherapy 08/2012